These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7001832)

  • 41. Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea.
    Gutniak M; Karlander SG; Efendić S
    Diabetes Care; 1987; 10(5):545-54. PubMed ID: 2890501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
    Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
    Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation.
    Mari A; Tura A; Gastaldelli A; Ferrannini E
    Diabetes; 2002 Feb; 51 Suppl 1():S221-6. PubMed ID: 11815483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of two periods with intensified insulin treatment on B-cell function during the first 18 months of type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S
    Diabete Metab; 1986 Oct; 12(5):256-60. PubMed ID: 3542618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of chronic insulin therapy on pancreatic A and B cell functions in type 2 diabetes].
    Tanaka A; Shima K
    Horumon To Rinsho; 1982 Jul; 30(7):693-8. PubMed ID: 6751622
    [No Abstract]   [Full Text] [Related]  

  • 48. Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.
    Mari A; Gastaldelli A; Natali A; Ostergard T; Schmitz O; Ferrannini E
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E541-6. PubMed ID: 15522997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pathogenetic relationship between insulin resistance, insulin secretion and impaired glucose tolerance in patients with obesity].
    Abdurakhmanova AM; Kosovskiĭ MI; Rakhimov NR; Guliamov TD
    Probl Endokrinol (Mosk); 1988; 34(2):21-4. PubMed ID: 3293029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment.
    Valensi P; Moura I; Le Magoarou M; Pariès J; Perret G; Attali JR
    Diabetes Metab; 1997 Feb; 23(1):51-7. PubMed ID: 9059766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endogenous insulin secretion measured by C-peptide in maturity-onset diabetes controllable by diet alone.
    Rendell M; Ross DA; Drew HM; Zarriello J
    Arch Intern Med; 1981 Nov; 141(12):1617-22. PubMed ID: 7030247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.
    Abbink EJ; van der Wal PS; Sweep CG; Smits P; Tack CJ
    Diabetes Metab Res Rev; 2004; 20(6):466-71. PubMed ID: 15386823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus.
    Gjessing HJ; Reinholdt B; Faber OK; Pedersen O
    Acta Endocrinol (Copenh); 1991 May; 124(5):556-62. PubMed ID: 2028714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-peptide responses after meal challenge in mice transplanted with microencapsulated rat islets.
    Tatarkiewicz K; Garcia M; Omer A; Van Schilfgaarde R; Weir GC; De Vos P
    Diabetologia; 2001 May; 44(5):646-53. PubMed ID: 11380084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beta-cell function across the spectrum of glucose tolerance in obese youth.
    Weiss R; Caprio S; Trombetta M; Taksali SE; Tamborlane WV; Bonadonna R
    Diabetes; 2005 Jun; 54(6):1735-43. PubMed ID: 15919795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The natural history of diabetes with respect to disorders of insulin function].
    Dorner M; Pinget M; Brogard JM; Sapin R; Paris-Bockel D; Levy P; Jung C
    Journ Annu Diabetol Hotel Dieu; 1984; ():51-71. PubMed ID: 6399540
    [No Abstract]   [Full Text] [Related]  

  • 57. Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
    Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Jos J; Boitard C; Assan R; Robert JJ
    Diabetes Care; 1995 Nov; 18(11):1487-90. PubMed ID: 8722075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beta-cell function recovery is not the only factor responsible for remission in type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase.
    Schober E; Schernthaner G; Frisch H; Fink M
    J Endocrinol Invest; 1984 Oct; 7(5):507-12. PubMed ID: 6392401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicity.
    Wolffenbuttel BH; Menheere PP; Nijst L; Rondas-Colbers GJ; Sels JP; Nieuwenhuijzen Kruseman AC
    Neth J Med; 1992 Jun; 40(5-6):277-82. PubMed ID: 1436266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of an artificial beta cell in surgery.
    Horwitz DL; Schwartz SS
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.